T2 Biosystems, Inc.
TTOO
$0.1255
-$0.006-4.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.88% | 33.77% | -30.89% | 32.97% | -143.03% |
| Total Depreciation and Amortization | -4.84% | -3.13% | -13.51% | -71.76% | -1.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 176.91% | -118.19% | 73.34% | -71.14% | 173.81% |
| Change in Net Operating Assets | 3,634.41% | 115.68% | -13.38% | 82.49% | -2,264.49% |
| Cash from Operations | 32.34% | 20.90% | -24.08% | 29.69% | -8.12% |
| Capital Expenditure | -- | -- | -- | -100.00% | 60.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -100.00% | 60.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -43.82% | 230.41% | 171.31% | -96.26% | 18.03% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -43.82% | 230.56% | 171.18% | -96.25% | 17.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.24% | 79.31% | -9.86% | -204.80% | 38.01% |
